dosage when switching from semaglutide to tirzepatide Semaglutide: What to Expect Semaglutide to Tirzepatide Dose Conversion

Simultaneously, Novo Nordisks SELECT trial confirmed a 20% reduction in major adverse cardiac events with semaglutide, expanding prescriber confidence and unlocking reimbursement across high-risk populations

The FDA approval of the first oral GLP-1 medication for obesity in December 2025 represents a major milestone in weight loss treatment options

Noom stands behind its program with a Taper-Off Guarantee offering a pathway off supposedly forever medications

Hwang D, Henry WS

The survey found 17 per cent said theyre considering adding the benefit, while 73 per cent said they currently exclude coverage through a carve-out in their medical and/or prescription drug plan